Our exclusive technology platform has unique advantages for creating better treatment options in cerebral aneurysm and better outcomes

LET’S MEET.

We are now accepting first round investments and ARE prepared to discuss our:

• Attractive business model and opportunity for next generation therapy devices
• Clinical & Regulatory strategy leading to the U.S. & rest of the world approvals
• Management, physicians, and scientific advisory board of experts in medical devices and clinical utility
• Preliminary plans including series A financing for activities leading to product launch